Back
Cartesian Therapeutics Vs. Amgen Industry Stock Comparison
Sell
37
RNAC
Cartesian Therapeutics
Last Price:
16.31
Seasonality Move:
-14.99%
Buy
63
AMGN
Amgen
Last Price:
334.90
Seasonality Move:
4.7%
Sell
37
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy, Sell or Hold?
- The current Cartesian Therapeutics [RNAC] share price is $16.75. The Score for RNAC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Amgen (AMGN)
is a Buy
Is Amgen a Buy, Sell or Hold?
- The current Amgen [AMGN] share price is $332.45. The Score for AMGN is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- AMGN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RNAC Stock Price Chart
What is Cartesian Therapeutics's stock price today?
-
The Cartesian Therapeutics share price today is $16.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAC is experiencing buying pressure, which is a positive indicator for future bullish movement.
AMGN Stock Price Chart
RNAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 60.37 | Buy |
| Chaikin Money Flow: | 26939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.19 - 15.15) | Buy |
| Bollinger Bands (100): | (14.16 - 27.02) | Sell |
AMGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.03 | Buy |
| Relative Strength Index (14 RSI): | 56.43 | Buy |
| Chaikin Money Flow: | 624331 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (323.36 - 330.76) | Buy |
| Bollinger Bands (100): | (298.7 - 331.54) | Buy |
RNAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.63 | Buy |
| 20-day SMA: | 14.35 | Buy |
| 50-day SMA: | 15.28 | Buy |
| 200-day SMA: | 20.86 | Sell |
| 8-day EMA: | 15.15 | Buy |
| 20-day EMA: | 14.69 | Buy |
| 50-day EMA: | 16.18 | Buy |
| 200-day EMA: | 21.88 | Sell |
AMGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 327.88 | Buy |
| 20-day SMA: | 328.12 | Buy |
| 50-day SMA: | 327.73 | Buy |
| 200-day SMA: | 300.12 | Buy |
| 8-day EMA: | 329.22 | Buy |
| 20-day EMA: | 328.18 | Buy |
| 50-day EMA: | 324.49 | Buy |
| 200-day EMA: | 301.69 | Buy |
Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $2.16 per share.
Amgen Earnings Growth & AMGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.41 per share, an increase this year of $0.98 per share, and an increase next year of $1.24 per share.
Cartesian Therapeutics Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amgen Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||